A genome-wide association study suggests new evidence for an association of the NADPH Oxidase 4 ( NOX 4 ) gene with severe diabetic retinopathy in type 2 diabetes

Purpose: Diabetic retinopathy is the most common eye complication in patients with diabetes. The purpose of this study is to identify genetic factors contributing to severe diabetic retinopathy. Methods: A genome-wide association approach was applied. In the Genetics of Diabetes Audit and Research in Tayside Scotland (GoDARTS) datasets, cases of severe diabetic retinopathy were defined as type 2 diabetic patients who were ever graded as having severe background retinopathy (Level R3) or proliferative retinopathy (Level R4) in at least one eye according to the Scottish Diabetic RetinopathyGrading Scheme or who were once treated by laser photocoagulation. Controlswerediabetic individualswhose longitudinal retinopathyscreeningrecords were either normal (LevelR0) or onlywithmild background retinopathy (Level R1) in both eyes. Significant Single Nucleotide Polymorphisms (SNPs) were taken forward for meta-analysis using multiple Caucasian cohorts. Results: Five hundred and sixty cases of type 2 diabetes with severe diabetic retinopathy and 4,106 controls were identified in the GoDARTS cohort. We revealed that rs3913535 in the NADPH Oxidase 4 (NOX4) gene reached a p value of 4.05 3 10 . Two nearby SNPs, rs10765219 and rs11018670 also showed promising p values (p values = 7.41 3 10 8 and 1.23 3 10 , respectively). In the meta-analysis using multiple Caucasian cohorts (excluding GoDARTS), rs10765219 and rs11018670 showed associations for diabetic retinopathy (p = 0.003 and 0.007, respectively), while the p value of rs3913535 was not significant (p = 0.429). Conclusion: This genome-wide association study of severe diabetic retinopathy suggests new evidence for the involvement of the NOX4 gene.

[1]  P. Kubatka,et al.  Nitric oxide in the pathophysiology of retinopathy: evidences from preclinical and clinical researches , 2017, Acta ophthalmologica.

[2]  Ellen T. Gelfand,et al.  A Novel Approach to High-Quality Postmortem Tissue Procurement: The GTEx Project , 2015, Biopreservation and biobanking.

[3]  M. Brown,et al.  Genome-wide association study for sight-threatening diabetic retinopathy reveals association with genetic variation near the GRB2 gene , 2015, Diabetologia.

[4]  H. Abboud,et al.  Targeting NADPH oxidase with a novel dual Nox1/Nox4 inhibitor attenuates renal pathology in type 1 diabetes. , 2015, American journal of physiology. Renal physiology.

[5]  Xun Xu,et al.  The 5-Year Onset and Regression of Diabetic Retinopathy in Chinese Type 2 Diabetes Patients , 2014, PloS one.

[6]  H. Schmidt,et al.  Nox‐4 deletion reduces oxidative stress and injury by PKC‐α‐associated mechanisms in diabetic nephropathy , 2014, Physiological reports.

[7]  J. Cunha-Vaz,et al.  Genetic Variants in ICAM1, PPARGC1A and MTHFR Are Potentially Associated with Different Phenotypes of Diabetic Retinopathy , 2014, Ophthalmologica.

[8]  R. Touyz,et al.  Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy. , 2014, Journal of the American Society of Nephrology : JASN.

[9]  J. Wang,et al.  NADPH Oxidase4-derived H2O2 Promotes Aberrant Retinal Neovascularization via Activation of VEGF Receptor 2 Pathway in Oxygen-induced Retinopathy , 2014 .

[10]  Jian-xing Ma,et al.  Salutary Effect of Fenofibrate on Diabetic Retinopathy via Inhibiting Oxidative Stress-mediated Wnt Pathway Activation , 2014 .

[11]  Zhihong Yang,et al.  Endothelial NADPH oxidase 4 mediates vascular endothelial growth factor receptor 2–induced intravitreal neovascularization in a rat model of retinopathy of prematurity , 2014, Molecular vision.

[12]  A. Morris,et al.  Glycemic Exposure and Blood Pressure Influencing Progression and Remission of Diabetic Retinopathy , 2013, Diabetes Care.

[13]  J M Sparrow,et al.  United Kingdom National Ophthalmology Database Study: Diabetic Retinopathy; Report 1: prevalence of centre-involving diabetic macular oedema and other grades of maculopathy and retinopathy in hospital eye services , 2013, Eye.

[14]  R. Klein,et al.  Genome-wide association study in a Chinese population with diabetic retinopathy. , 2013, Human molecular genetics.

[15]  K. Block,et al.  Nox4 and diabetic nephropathy: with a friend like this, who needs enemies? , 2013, Free radical biology & medicine.

[16]  Nicholas R. Lemoine,et al.  A practical guide for the functional annotation of genetic variations using SNPnexus , 2013, Briefings Bioinform..

[17]  P. Calvas,et al.  A genome-wide association study provides evidence for association of chromosome 8p23 (MYP10) and 10q21.1 (MYP15) with high myopia in the French Population. , 2012, Investigative ophthalmology & visual science.

[18]  Y. Da,et al.  SNPEVG: a graphical tool for GWAS graphing with mouse clicks , 2012, BMC Bioinformatics.

[19]  Xianglin Shi,et al.  NADPH Oxidase 4 Mediates Insulin-Stimulated HIF-1α and VEGF Expression, and Angiogenesis In Vitro , 2012, PloS one.

[20]  J. Olson,et al.  Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland , 2012, Diabetologia.

[21]  L. Groop,et al.  SNP in the genome-wide association study hotspot on chromosome 9p21 confers susceptibility to diabetic nephropathy in type 1 diabetes , 2012, Diabetologia.

[22]  S. Tiefenbrun.  STARR COUNTY (Texas) , 2012 .

[23]  Liang Xu,et al.  PREVALENCE AND RISK FACTORS FOR DIABETIC RETINOPATHY: The Beijing Communities Diabetes Study 6 , 2012, Retina.

[24]  O. Delaneau,et al.  A linear complexity phasing method for thousands of genomes , 2011, Nature Methods.

[25]  F. Tsai,et al.  Genome-wide association study of diabetic retinopathy in a Taiwanese population. , 2011, Ophthalmology.

[26]  D. Nicolae,et al.  Genome-wide meta-analysis for severe diabetic retinopathy. , 2011, Human molecular genetics.

[27]  P. Visscher,et al.  Estimating missing heritability for disease from genome-wide association studies. , 2011, American journal of human genetics.

[28]  Peter Donnelly,et al.  Edinburgh Research Explorer Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes , 2022 .

[29]  R. Klein,et al.  Identification of Diabetic Retinopathy Genes through a Genome-Wide Association Study among Mexican-Americans from Starr County, Texas , 2010, Journal of ophthalmology.

[30]  L. Levin,et al.  Prevalence and healthcare costs of diabetic retinopathy: a population-based register study in Sweden , 2010, Diabetologia.

[31]  Reedik Mägi,et al.  GWAMA: software for genome-wide association meta-analysis , 2010, BMC Bioinformatics.

[32]  N. Petrovsky,et al.  Aldose Reductase Gene Polymorphisms and Diabetic Retinopathy Susceptibility , 2010, Diabetes Care.

[33]  Kai Chen,et al.  Inhibition of Reactive Oxygen Species by Lovastatin Downregulates Vascular Endothelial Growth Factor Expression and Ameliorates Blood-Retinal Barrier Breakdown in db/db Mice , 2010, Diabetes.

[34]  P. Donnelly,et al.  A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies , 2009, PLoS genetics.

[35]  David M Nathan,et al.  Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial. , 2008, Archives of ophthalmology.

[36]  C. Bunce,et al.  Causes of blind certifications in England and Wales: April 1999–March 2000 , 2008, Eye.

[37]  M. McCarthy,et al.  Genome-wide association studies for complex traits: consensus, uncertainty and challenges , 2008, Nature Reviews Genetics.

[38]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[39]  R. Klein,et al.  Genome-Wide Linkage Analyses to Identify Loci for Diabetic Retinopathy , 2007, Diabetes.

[40]  R. Klein,et al.  The economic burden of major adult visual disorders in the United States. , 2006, Archives of ophthalmology.

[41]  L. Groop,et al.  The −374 T/A polymorphism in the gene encoding RAGE is associated with diabetic nephropathy and retinopathy in type 1 diabetic patients , 2006, Diabetologia.

[42]  A. Morris,et al.  Implementation of national diabetes retinal screening programme is associated with a lower proportion of patients referred to ophthalmology , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[43]  J. C. Huber,et al.  Familial aggregation of severity of diabetic retinopathy in Mexican Americans from Starr County, Texas. , 2005, Diabetes care.

[44]  K. Schulz,et al.  Compared to what? Finding controls for case-control studies , 2005, The Lancet.

[45]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[46]  J. Forrester,et al.  Epidemiology of diabetic retinopathy and macular oedema: a systematic review , 2004, Eye.

[47]  T. Kennedy-Martin,et al.  The influence of diabetic retinopathy on quality of life: interviews to guide the design of a condition-specific, individualised questionnaire: the RetDQoL. , 2004, Patient education and counseling.

[48]  V. Mohan,et al.  Familial clustering of diabetic retinopathy in South Indian Type 2 diabetic patients , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[49]  Stephen J. Aldington,et al.  Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52) , 2001, Diabetic medicine : a journal of the British Diabetic Association.

[50]  Stephen J. Aldington,et al.  UKPDS 50: Risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis , 2001, Diabetologia.

[51]  Diabetes Control.  Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group. , 1994, The Journal of pediatrics.

[52]  D. Pyke,et al.  Diabetic Retinopathy in Identical Twins , 1982, Diabetes.

[53]  Tanya M. Teslovich,et al.  LocusZoom: regional visualization of genome-wide association scan results , 2010, Bioinform..

[54]  P A Cleary,et al.  Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). , 2001, The Journal of pediatrics.

[55]  J. Thomison,et al.  Compared to what? , 1990, Journal of the Tennessee Medical Association.

[56]  Glycemic Exposure and Blood Pressure In fl uencing Progression and Remission of Diabetic Retinopathy A longitudinal cohort study in GoDARTS , 2022 .